Literature DB >> 12438588

Newcastle disease virus HN protein alters the conformation of the F protein at cell surfaces.

Lori W McGinnes1, Kathryn Gravel, Trudy G Morrison.   

Abstract

Conformational changes in the Newcastle disease virus (NDV) fusion (F) protein during activation of fusion and the role of HN protein in these changes were characterized with a polyclonal antibody. This antibody was raised against a peptide with the sequence of the amino-terminal half of the F protein HR1 domain. This antibody immunoprecipitated both F(0) and F(1) forms of the fusion protein from infected and transfected cell extracts solubilized with detergent, and precipitation was unaffected by expression of the HN protein. In marked contrast, this antibody detected significant conformational differences in the F protein at cell surfaces, differences that depended upon HN protein expression. The antibody minimally detected the F protein, either cleaved or uncleaved, in the absence of HN protein expression. However, when coexpressed with HN protein, an uncleaved mutant F protein bound the anti-HR1 antibody, and this binding depended upon the coexpression of specifically the NDV HN protein. When the cleaved wild-type F protein was coexpressed with HN protein, the F protein bound anti-HR1 antibody poorly although significantly more than F protein expressed alone. Anti-HR1 antibody inhibited the fusion of R18 (octadecyl rhodamine B chloride)-labeled red blood cells to syncytia expressing HN and wild-type F proteins. This inhibition showed that fusion-competent F proteins present on surfaces of syncytia were capable of binding anti-HR1. Furthermore, only antibody which was added prior to red blood cell binding could inhibit fusion. These results suggest that the conformation of uncleaved cell surface F protein is affected by HN protein expression. Furthermore, the cleaved F protein, when coexpressed with HN protein and in a prefusion conformation, can bind anti-HR1 antibody, and the anti-HR1-accessible conformation exists prior to HN protein attachment to receptors on red blood cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438588      PMCID: PMC136696          DOI: 10.1128/jvi.76.24.12622-12633.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Mutations in the cytoplasmic domain of the fusion glycoprotein of Newcastle disease virus depress syncytia formation.

Authors:  T Sergel; T G Morrison
Journal:  Virology       Date:  1995-07-10       Impact factor: 3.616

Review 2.  Paramyxovirus fusion: a hypothesis for changes.

Authors:  R A Lamb
Journal:  Virology       Date:  1993-11       Impact factor: 3.616

3.  The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation.

Authors:  T Sergel; L W McGinnes; M E Peeples; T G Morrison
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

4.  The fusion promotion activity of the NDV HN protein does not correlate with neuraminidase activity.

Authors:  T Sergel; L W McGinnes; T G Morrison
Journal:  Virology       Date:  1993-10       Impact factor: 3.616

5.  Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion.

Authors:  T Sergel-Germano; C McQuain; T Morrison
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein.

Authors:  R Russell; R G Paterson; R A Lamb
Journal:  Virology       Date:  1994-02-15       Impact factor: 3.616

7.  Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.

Authors:  D M Lambert; S Barney; A L Lambert; K Guthrie; R Medinas; D E Davis; T Bucy; J Erickson; G Merutka; S R Petteway
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

8.  Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion.

Authors:  G W Kemble; T Danieli; J M White
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

9.  Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein.

Authors:  J N Reitter; T Sergel; T G Morrison
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses.

Authors:  D Rapaport; M Ovadia; Y Shai
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

View more
  28 in total

1.  The transmembrane domain sequence affects the structure and function of the Newcastle disease virus fusion protein.

Authors:  Kathryn A Gravel; Lori W McGinnes; Julie Reitter; Trudy G Morrison
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model.

Authors:  Sompong Vongpunsawad; Numan Oezgun; Werner Braun; Roberto Cattaneo
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Requirements for the assembly and release of Newcastle disease virus-like particles.

Authors:  Homer D Pantua; Lori W McGinnes; Mark E Peeples; Trudy G Morrison
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

4.  Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein.

Authors:  Tatiana Bousse; Toru Takimoto
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  A histidine switch in hemagglutinin-neuraminidase triggers paramyxovirus-cell membrane fusion.

Authors:  Anuja Krishnan; Santosh K Verma; Prashant Mani; Rahul Gupta; Suman Kundu; Debi P Sarkar
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

6.  Designing a Novel Recombinant HN Protein with Multi Neutralizing Antigenic Sites and Auto Tag Removal Ability Based on NDV-VIIj for Diagnosis and Vaccination Application.

Authors:  Vafa Mayahi; Majid Esmaelizad; Naser Harzandi
Journal:  Indian J Microbiol       Date:  2018-04-25       Impact factor: 2.461

7.  Interacting domains of the HN and F proteins of newcastle disease virus.

Authors:  Kathryn A Gravel; Trudy G Morrison
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Overexpression of thiol/disulfide isomerases enhances membrane fusion directed by the Newcastle disease virus fusion protein.

Authors:  Surbhi Jain; Lori W McGinnes; Trudy G Morrison
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

9.  Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.

Authors:  Matthew R Murawski; Lori W McGinnes; Robert W Finberg; Evelyn A Kurt-Jones; Michael J Massare; Gale Smith; Penny M Heaton; Armando E Fraire; Trudy G Morrison
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

10.  Nucleotide and predicted amino acid sequence analysis of the fusion protein and hemagglutinin-neuraminidase protein genes among Newcastle disease virus isolates. Phylogenetic relationships among the Paramyxovirinae based on attachment glycoprotein sequences.

Authors:  Bruce S Seal
Journal:  Funct Integr Genomics       Date:  2004-04-24       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.